PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Biomea Fusion, Inc. (BMEA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS09077A1060
CUSIP09077A106
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$567.01M
EPS-$3.33
EBITDA (TTM)-$113.81M
Year Range$8.13 - $43.69
Target Price$54.43
Short %54.04%
Short Ratio13.00

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BMEA

Biomea Fusion, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Biomea Fusion, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%OctoberNovemberDecember2024FebruaryMarch
-17.42%
25.40%
BMEA (Biomea Fusion, Inc.)
Benchmark (^GSPC)

S&P 500

Returns By Period

Biomea Fusion, Inc. had a return of 5.79% year-to-date (YTD) and -49.98% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date5.79%10.04%
1 month-8.84%3.53%
6 months10.58%22.79%
1 year-49.98%32.16%
5 years (annualized)N/A13.15%
10 years (annualized)N/A10.96%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202424.52%-3.21%
2023-24.18%-18.44%-25.73%47.46%-3.65%

Risk-Adjusted Performance

Risk-Adjusted Performance Indicators

This table presents risk-adjusted performance metrics for Biomea Fusion, Inc. (BMEA) and compares them with a selected benchmark (^GSPC). These performance indicators assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
BMEA
Biomea Fusion, Inc.
-0.00
^GSPC
S&P 500
2.76

Sharpe Ratio

The current Biomea Fusion, Inc. Sharpe ratio is -0.00. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00OctoberNovemberDecember2024FebruaryMarch
-0.00
2.76
BMEA (Biomea Fusion, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Biomea Fusion, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-63.25%
0
BMEA (Biomea Fusion, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Biomea Fusion, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Biomea Fusion, Inc. was 85.67%, occurring on Apr 29, 2022. Recovery took 228 trading sessions.

The current Biomea Fusion, Inc. drawdown is 63.25%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-85.67%Jun 11, 2021224Apr 29, 2022228Mar 28, 2023452
-79.98%Jun 9, 2023109Nov 13, 2023
-25.87%Mar 30, 202311Apr 14, 202315May 5, 202326
-14.68%Apr 19, 202120May 14, 202111Jun 1, 202131
-8.65%May 15, 20237May 23, 20236Jun 1, 202313

Volatility

Volatility Chart

The current Biomea Fusion, Inc. volatility is 25.15%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%60.00%OctoberNovemberDecember2024FebruaryMarch
25.15%
2.82%
BMEA (Biomea Fusion, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Biomea Fusion, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

0.00

Cost Of Revenue

0.00

Gross Profit

0.00
Operating Expenses

Selling, General & Admin Expenses

0.00

R&D Expenses

0.00

Total Operating Expenses

0.00
Income

Income Before Tax

0.00

Operating Income

0.00

EBIT

0.00

Earnings From Continuing Operations

0.00

Net Income

0.00

Income Tax Expense

0.00

Interest Expense

0.00

Other Non-Operating Income (Expenses)

0.00

Extraordinary Items

0.00

Discontinued Operations

0.00

Effect Of Accounting Charges

0.00

Non Recurring

0.00

Minority Interest

0.00

Other Items

0.00
Values in undefined except per share items